LANTINE

This brand name is authorized in Nigeria.

Active ingredients

The drug LANTINE contains one active pharmaceutical ingredient (API):

1	Loratadine UNII 7AJO3BO7QN - LORATADINE
	Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage.
	Read more about Loratadine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-3977	Tablet	LANTINE 10 TABLETS TAB 10 mg	LANTINE 10 TABLETS LORATADINE 10MG LORATADINE 10mg, Magnesium Hydroxide-98.00, Microcrystalline Cellulose-67.78, Polvinyl Pyrrolidone -2.20, Isopropyl Alcohol-QS, Colour Titanium Di oxide-0.02, Loratadine10.0, Kyron-T-314 5.0, Aspartame-4.0, Purified Talc-6.0, Colloidal Silicon dioxide-2.0, Magnesium Stearate -6.0, Flavour Pineapple STR DM-2.0, Sodium hydrogen carbonate-37.0. A4-3977 Drugs Imported Products 10x10 Over The Counter (OTC) 08/05/2023 APHANTEE PHARM NIGERIA LTD, SUITE FF 11, PACIFIC COMPLEX AWKA ROAD ONITSHA ANAMBRA 8077261675 aphanteepharm@yahoo.com M/S MCW HEALTHCARE(P) LTD, 286, 287-A, 287-B, SECTOR-E, INDUSTRIAL AREA, SANWER ROAD, INDORE (M.P), INDIA, India	31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R06AX13	Loratadine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-3977